CRP and rheumatoid arthritis: For the inflammatory arthritis phase in the preclinical stage of RA, classical biomarkers such as erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) cannot elucidate lymphocyte subset imbalances or early immune microenvironment alterations (24), leaving clinical decisions devoid of precise immunological context.